About: Epoprostenol Sodium

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Epoprostenol Sodium Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	Class
rdfs:label	Epoprostenol Sodium
rdfs:subClassOf	Antihypertensive Agent Prostaglandins, Synthetic
Has_Free_Acid_Or_Base_Form	EPOPROSTENOL
Concept_In_Subset	FDA Established Names and Unique Ingredient Identifier Codes Terminology
Semantic_Type	Pharmacologic Substance
Preferred_Name	Epoprostenol Sodium
UMLS_CUI	C0354594
CAS_Registry	61849-14-7
FDA_UNII_Code	4K04IQ1OF4
Contributing_Source	FDA
Chemical_Formula	C20H31O5.Na
Legacy_Concept_Name	Epoprostenol_Sodium
FULL_SYN	Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, Sodium salt, (5Z,9alpha,11alpha,13E,15S)-SNNCI Cyclo-ProstinSYNCI Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerateSNNCI FlolanBRNCI Epoprostenol SodiumPTNCI EPOPROSTENOL SODIUMPTFDA4K04IQ1OF4
DEFINITION	The sodium salt form of epoprostenol, a synthetic prostacyclin, a member of the family of prostaglandins, with vasodilatory and anticoagulant activity. Epoprostenol sodium directly simulates prostaglandin receptors in arterial vascular smooth muscle, thereby causing vasodilatation. This agent also inhibits platelet aggregation by antagonizing platelet glycoprotein (GP) IIb/IIIa receptors, thereby preventing thrombus formation.NCI
code	C47514
is Has_Salt_Form of	EPOPROSTENOL

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software